FBL and diabetes mellitus: In this study, we found that Fib-4 could predict cirrhosis well in both people with and without diabetes (AUCROC: 0.839 and 0.841), and it was better than the prediction accuracy of KM’s study for advanced liver fibrosis in obese people (AUCROC: 0.74) (35).